Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-10

Clinical Trial Update: How Orally Consumed 3-hydroxybuturate Alters Metabolism [NA]

View source ↗

Summary

This clinical trial update reports completion of a study investigating how orally administered 3-hydroxybutyrate affects metabolism in individuals with acute ke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 3-hydroxybutyrate (beta-hydroxybutyrate)

Snippet

Sponsor: University of Aarhus | Conditions: Acute Ketosis | NA | Status: COMPLETED